Antigenic shift and increased incidence of meningococcal disease

被引:78
作者
Harrison, LH
Jolley, KA
Shutt, KA
Marsh, JW
O'Leary, M
Sanza, LT
Maiden, MCJ
机构
[1] Univ Pittsburgh, Infect Dis Epidemiol Res Unit, Grad Sch Publ Hlth, Div Infect Dis, Pittsburgh, PA 15261 USA
[2] Sch Med, Pittsburgh, PA USA
[3] Univ Oxford, Dept Zool, Oxford OX1 3PS, England
[4] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA
基金
英国惠康基金;
关键词
D O I
10.1086/501371
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. The incidence of serogroup C and Y meningococcal disease increased in the United States during the 1990s. The cyclical nature of endemic meningococcal disease remains unexplained. The purpose of this study was to investigate the mechanisms associated with the increase in the incidence of meningococcal disease. Methods. We characterized an increasing incidence of invasive serogroup C and Y meningococcal disease using population-based surveillance from 1992 through 2001. Isolates were characterized by multilocus sequence typing and antigen sequence typing of 3 outer membrane protein (OMP) genes: porA variable regions (VRs) 1 and 2, porB, and fetA VR. Results. For both serogroups, OMP antigenic shifts were associated with increased incidence of meningococcal disease. For serogroup Y, antigenic shift occurred through amino acid substitutions at all 3 OMPs-PorA VR 1 and 2, PorB, and FetA VR. For serogroup C, antigenic shift involved amino acid substitutions at FetA VR and, in some cases, deletion of the porA gene. On the basis of deduced amino acid sequences, the antigenic changes likely occurred by horizontal gene transfer. Conclusions. Antigenic shifts were associated with increased incidence of serogroup C and serogroup Y meningococcal disease. For serogroup Y, the changes involved all OMP genes that were studied. Increases in the incidence of meningococcal disease may be caused, in part, by antigenic shift.
引用
收藏
页码:1266 / 1274
页数:9
相关论文
共 45 条
[41]   ANTIGENIC AND EPIDEMIOLOGIC PROPERTIES OF THE ET-37 COMPLEX OF NEISSERIA-MENINGITIDIS [J].
WANG, JF ;
CAUGANT, DA ;
MORELLI, G ;
KOUMARE, B ;
ACHTMAN, M .
JOURNAL OF INFECTIOUS DISEASES, 1993, 167 (06) :1320-1329
[42]   SEROTYPING AND SUBTYPING OF NEISSERIA-MENINGITIDIS ISOLATES BY COAGGLUTINATION, DOT-BLOTTING AND ELISA [J].
WEDEGE, E ;
HOIBY, EA ;
ROSENQVIST, E ;
FROHOLM, LO .
JOURNAL OF MEDICAL MICROBIOLOGY, 1990, 31 (03) :195-201
[43]   Immunization with the recombinant PorB outer membrane protein induces a bactericidal immune response against Neisseria meningitidis [J].
Wright, JC ;
Williams, JN ;
Christodoulides, M ;
Heckels, JE .
INFECTION AND IMMUNITY, 2002, 70 (08) :4028-4034
[44]   IMMUNOLOGICAL RESPONSE OF MAN TO GROUP B MENINGOCOCCAL POLYSACCHARIDE VACCINES [J].
WYLE, FA ;
TRAMONT, EC ;
LOWENTHAL, JP ;
BERMAN, SL ;
BRANDT, BL ;
ALTIERI, PL ;
ARTENSTEIN, MS ;
KASPER, DL .
JOURNAL OF INFECTIOUS DISEASES, 1972, 126 (05) :514-+
[45]   School-based clusters of meningococcal disease in the United States - Descriptive epidemiology and a case-control analysis [J].
Zangwill, KM ;
Schuchat, A ;
Riedo, FX ;
Pinner, RW ;
Koo, DT ;
Reeves, MW ;
Wenger, JD .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1997, 277 (05) :389-395